Objective: A dearth of studies focusing on young women (<40 years) with breast cancer have hampered the understanding of the type, prevalence, and predictors of sexual dysfunction and reproductive concerns in this population.
| INTRODUCTION
Women diagnosed with breast cancer at a young age face unique challenges and demands. First, young age at diagnosis (<40 years) is linked to genetically more aggressive tumors, 1 poorer prognosis with increased mortality, and more extensive treatments. 2 Second, a diagnosis of breast cancer during one's reproductive years may interfere with important life goals such as building intimate relationships and having children. 3 Also, young women may be at particular risk of sexual problems due to a higher vulnerability to hormonal changes caused by cancer treatment and more concerns about body image after, eg, breast cancer surgery. 4, 5 Few studies have however investigated these important issues, resulting in a lack of knowledge regarding sexual function and reproductive concerns in young women with breast cancer.
Common breast cancer treatments such as chemotherapy and endocrine treatments may have a negative impact on fertility. Chemotherapy directly induces a risk of infertility via temporary or permanent ovarian failure and amenorrhea. 6, 7 The dominating endocrine treatment used in this age group (tamoxifen) on the other hand is mainly indirectly linked to inability to conceive due to its feto-toxicity, imposing women to avoid pregnancy during this often lengthy treatment. 8 Reproductive concerns in the context of cancer extend beyond the biological fertility potential and include concerns about recurrence, living long enough to raise children, discussing fertility problems with a partner, acceptance of possible infertility, and concerns regarding the child's health. 9, 10 This multidimensional concept was developed based on young female survivors' identification of important aspects related to reproduction and thus includes a range of concerns related to fertility and parenthood after cancer. 9 Reproductive concerns have been associated with decreased quality of life (QoL) 3, 11 and long-term depressive symptoms in women with cancer. 12 A wish for children, low number of prior pregnancies, prior difficulty conceiving, and being nulliparous at diagnosis have been reported to increase the risk of high levels of reproductive concerns. 10, 12 Sexual dysfunction, such as a reduction in desire, lubrication difficulties, and vaginal pain and discomfort, has been reported by women with breast cancer. 4, [13] [14] [15] 4 Similar results have been reported for young adults (<40 years) with different types of cancers where a negative perception of one's physical appearance was shown to predict sexual problems. 24 Canada and Schover (2012) have furthermore reported that women who view themselves as infertile experience lower sexual satisfaction than women who believe they have normal fertility, pointing to the potential intricate interdependence between these issues. 25 The overall aim of the current study was to investigate sexual dysfunction and reproductive concerns in women under the age of 40 at breast cancer diagnosis. The study also aimed to identify predictors of high levels of problems and the potential interdependence between sexual dysfunction and reproductive concerns.
| METHODS

| Participants and procedure
Participants were identified using the Swedish National Quality
Registry for Breast Cancer which is a high-quality registry with almost complete coverage. 26 Identification criteria included women diagnosed with invasive breast cancer at the age of 18 to 39 in Sweden 
| Socio-demographic variables
Study specific questions were used to assess socio-demographic information including birth country, education, employment, family situation (partner, children), and wish for (additional) children.
| Sexual function
Sexual function was assessed using the Patient-Reported Outcomes Measurement Information System® Sexual Function and Satisfaction measure version 2.0 (SexFS). 27 The following five domains were selected: vaginal lubrication (two items), vaginal discomfort (four items), vulvar discomfort-clitoral (one item), vulvar discomfort-labial
(1 item), and satisfaction with sex life (two items). Scores were transformed to a T-score metric with 50 corresponding to the mean of the population of US adults who have been sexually active in the past 30 days. 27 We considered one standard deviation (10 points on the T-scale) under/above 50 as indicative of dysfunction. For "Satisfaction with sex life" and "Lubrication," lower scores indicate more problems and in the three discomfort domains higher scores indicate more problems. One question concerning reasons for not having had sexual activity with a partner during the past 30 days was also included. The SexFS has shown adequate content and construct validity and test-retest reliability. 27, 28 We translated the SexFS-v2 into Swedish and linguistically validated it in accordance with the procedure developed by FACITrans and PROMIS. 
| Reproductive concerns
Reproductive concerns were assessed using the Reproductive Concerns After Cancer scale (RCAC). 9 The RCAC is a multidimensional scale assessing a range of reproductive and parenthood concerns developed and evaluated for young adult female cancer survivors. 9 The scale encompasses 18 items scored on a five-point scale ranging from 1 = "Strongly disagree" to 5 = "Strongly agree", and includes the six dimensions: "Fertility potential," "Partner disclosure," "Child's health," "Personal health," "Acceptance," and "Becoming pregnant."
For each dimension, a mean value of >4 indicates a high level of reproductive concern. 9 The RCAC has demonstrated satisfactory internal consistency and construct validity. 30 The scale was independently translated into Swedish by two bilingual researchers, evaluated by two lay panels (n = 7) and one patient panel (n = 12), and in cognitive interviews with three young cancer patients.
| Body image
Body image was assessed using the Body Image Scale (BIS) which assesses body image discomfort associated with cancer. 31 The BIS consists of 10 items, and responses are given on a 4-point scale, from "not at all" (0) to "very much" (3) with higher scores indicating a positive body image. The BIS has shown high test-retest reliability and internal consistency (Cronbach's Alpha 0.93) in a sample of cancer patients. 31 Cronbach's Alpha for the BIS in the current study was 0.91.
| Health-related quality of life
Health-related QoL was measured using the EORTC QLQ-C30 version 3.0 (QLQ-30-v3.0), which is a 30-item questionnaire developed to assess the QoL of cancer patients. 32, 33 The QLQ-30 has demonstrated good psychometric properties in cancer populations. 32, 34 In the current study, the summary score (higher values reflect better QoL) was used according to the EORTC QLQ-C30 Scoring Manual (3rd Edition) (2001) and Geisinger et al (2016). Cronbach's alpha for the QLQ- 30-v3 .0 in the current study was 0.93.
| Statistical analyses
Fisher's exact test was used to analyze differences between responders and non-responders. Prevalence of sexual dysfunction and reproductive concerns was calculated using descriptive statistics.
The relationships between the domains of the SexFS and the dimensions of the RCAC were analyzed by Pearson's correlation coefficient.
Predictors for sexual dysfunction and reproductive concerns were identified using multivariable binary logistic regression with effects expressed as odds ratios (OR) using 95% confidence intervals (CI).
Four models were specified with variables selected beforehand according to previous literature on potentially important factors for the outcomes. Satisfaction with sex-life, vaginal lubrication, and vaginal discomfort were used as outcomes for sexual problems. For reproductive concerns, an overall indicator of a high level of problems (at least one dimension >4) was used. Variables included as predictors in the four models were current age (-35y; 36-40 y; 41-y), education ("university degree"; "no university degree"), employment status ("full-time"; "not-full-time"), birth country ("Sweden"; "other"), have children ("yes"; "no"), current partner relationship ("yes"; "no"), days since diagnosis (continuous variable), previous cancer treatment ("radiation therapy"; "chemotherapy"; "targeted therapy"), distant metastases ("yes"; "no"), mastectomy ("yes"; "no"), current endocrine treatment ("yes"; "no"), menstruation status ("regular"; "irregular"; "no menstruation past 6 months"), fertility preservation ("yes"; "no"), wish for (additional) children ("yes"; "uncertain"/"no"), satisfaction with sex life before cancer ("low"; "moderate"; "high"), BIS (continuous variable),
and QLQ-30-summary score (continuous variable). The models were evaluated using significance level P < 0.05 and Nagelkerke's R 4 | RESULTS
| Participants
Of the 301 individuals matching the inclusion criteria, 181 returned the questionnaire representing a response rate of 60%. There were no statistically significant differences between responders and nonresponders with regard to age or previous treatment modalities.
Fewer responders had distant metastases (P = 0.042); however, very few individuals had such metastases: two responders vs seven nonresponders.
Mean age at diagnosis was 34.6 years (SD = 4.1; range = 21-39), and mean current age was 36.5 years (SD = 4.1; range = 23-42).
Sweden 
| Sexual function
Sexual dysfunction in at least one domain was reported by 68%, and dysfunction in at least two domains was reported by 38% ( Table 2 ).
The most common problem was vulvar discomfort of the labia, reported by 40%. The most common reasons why participants had not had sex with a partner during the past 30 days were "Feeling unattractive" (51%), "Too tired" (49%), and "Dryness or pain in the vagina" (36%) ( Table 3 ).
| Reproductive concerns
At least one dimension of high level of reproductive concerns was reported by 58%, and at least two dimensions of high levels were reported by 22% ( Table 2 ). The most common areas of concern were "Child's health" and "Personal health," reported by 38% and 21%, respectively.
| Relation between sexual function and reproductive concerns
Correlations between the domains of sexual function and dimensions of reproductive concerns were small, ranging from 0.01 to −0.21.
The highest correlation was observed between the SexFS domain
"Satisfaction with sex-life" and the RCAC dimension "Personal health"
(Pearson r = −0.21). 
| Predictors of sexual dysfunction and reproductive concerns
Model results showed that endocrine treatment was a significant predictor of dysfunction related to lubrication (OR 3.8, 95% CI 1.2-12.1) and vaginal discomfort (OR 8.7, 95% CI 1.5-51.5). BIS was a significant predictor of dysfunction with regard to satisfaction with sex life (OR (Table 4) .
| DISCUSSION
The current study shows that sexual problems and reproductive concerns are common approximately 2 years post diagnosis in young women diagnosed with breast cancer. Two in three women reported at least one domain of sexual dysfunction. This is a much higher number compared with women in the general population where 10% report having sexual problem. 35 The prevalence of problems in this study is also higher compared with older women with breast cancer. A high level of reproductive concerns (at least one domain) was reported by 58% of the women which is comparable to previous findings (eg, Ganz 6 ). The most common areas of concern were "Child health" and "Personal health." These figures however diverse some from previous findings reporting "Fertility potential" to be a more common concern. 30 Our results should be seen in the context of the high degree of participants who already had children (77%), and the rather low number of participants who wished for (additional) children in the future (36%) which implies a lower level of concerns regarding ability to become pregnant. Still, the overall prevalence of reproductive concerns in our study is high pointing to the relevance of this concept also for women who already are mothers.
The predictor of reproductive concerns with the highest OR (3.5)
was "a wish for (additional) children." This is an expected finding that supports previous research in women with breast cancer 10 and underscores the relevance of inquiring about patients' reproductive intentions in connection with oncological treatment as well as after end of initial treatment and surgery. Chemotherapy was also a significant predictor of reproductive concerns, which may reflect participants' awareness of the negative impact chemotherapy has on fertility. 38 There was a weak relationship between sexual dysfunction and reproductive concerns, and few shared predictors, suggesting separate mechanisms to be involved in these issues. Reproductive concerns 
Cronbach's Alpha
Vaginal lubrication (n = 149) 45.9 (9.6) 42 (28) .85
Vaginal discomfort (n = 147) 52.8 (10.7) 32 (22 
| Study limitations
This study has important methodological strengths as well as weak- 
| Clinical implications
The current study shows that sexual dysfunction and reproductive 
